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Abstract
The C-terminal tail (CTT) of the HIV-1 gp41 envelope (Env) protein is increasingly recognized as an important determinant of
Env structure and functional properties, including fusogenicity and antigenicity. While the CTT has been commonly referred
to as the ‘‘intracytoplasmic domain’’ based on the assumption of an exclusive localization inside the membrane lipid bilayer,
early antigenicity studies and recent biochemical analyses have produced a credible case for surface exposure of specific
CTT sequences, including the classical ‘‘Kennedy epitope’’ (KE) of gp41, leading to an alternative model of gp41 topology
with multiple membrane-spanning domains. The current study was designed to test these conflicting models of CTT
topology by characterizing the exposure of native CTT sequences and substituted VSV-G epitope tags in cell- and virion-
associated Env to reference monoclonal antibodies (MAbs). Surface staining and FACS analysis of intact, Env-expressing cells
demonstrated that the KE is accessible to binding by MAbs directed to both an inserted VSV-G epitope tag and the native
KE sequence. Importantly, the VSV-G tag was only reactive when inserted into the KE; no reactivity was observed in cells
expressing Env with the VSV-G tag inserted into the LLP2 domain. In contrast to cell-surface expressed Env, no binding of
KE-directed MAbs was observed to Env on the surface of intact virions using either immune precipitation or surface plasmon
resonance spectroscopy. These data indicate apparently distinct CTT topologies for virion- and cell-associated Env species
and add to the case for a reconsideration of CTT topology that is more complex than currently envisioned.
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Introduction
Human immunodeficiency virus (HIV) infects humans predom-
inantly through interaction of the viral envelope glycoprotein (Env)
with the primary receptor CD4 and coreceptors CCR5 or
CXCR4 on the surface of target cells. Env is produced as a
160 kDa polyprotein that is subsequently processed by extensive
glycosylation, multimerization, and proteolytic cleavage to yield
the virion-associated trimeric complexes of non-covalently associ-
ated gp120-gp41 dimers [1,2]. Numerous studies have identified
Env as a primary determinant of viral phenotypes; variations in
Env sequence can affect cellular tropism, viral replication levels,
immune recognition, and pathogenesis [1,2]. Additionally, Env
sequence variation has recently been experimentally demonstrated
to be a primary determinant of lentivirus vaccine efficacy [3]. The
majority of Env structural studies have focused on gp120 and the
ectodomain of gp41; there is to date no definitive structural
information on the approximately 150 amino acid long C-terminal
tail that follows the proposed membrane-spanning domain (MSD)
of gp41.
Studies addressing the CTT have traditionally examined: (i) the
role of the CTT in viral Env incorporation [4,5,6,7]; (ii) the
influence of the CTT on virion maturation [4,8,9]; and (iii) the
function of predicted endocytic signals present in the CTT
[10,11]. Various studies of the interactions of both cellular and
other viral proteins as intracellular partners with Env have
implicitly reinforced the traditional model of CTT topology as
being localized completely within the inner surface of the cell or
viral lipid membrane (Figure 1A).
Early evidence for an alternative topological model for the CTT
was provided by Kennedy and colleagues [12,13] who first
reported that antiserum produced against a synthetic peptide from
gp41 (residues 728–745) bound to HIV-1 Env, and that serum
from HIV-1-infected humans also recognized this synthetic
peptide [12]. Importantly, this group subsequently reported that
antiserum raised against this synthetic peptide could specifically
neutralize HIV in vitro [13]. These observations indicated
exposure of the Kennedy epitope (KE) on the virion surface to
allow antibody binding and neutralization, in direct contrast to the
presumed intracytoplasmic location of the entire C-terminal
sequences of gp41 following the MSD.
More recently, Dimmock and colleagues have attempted to
address this apparent discrepancy between the traditional model of
an exclusively intracytoplasmic CTT and an alternative model
where the KE is exposed [14,15]. Using antibodies directed to the
739ERDRD743 sequence and MAbs directed to the upstream
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727PDRPEG732 and 733IEEE736 sequences in the KE,
Dimmock and colleagues demonstrated virion binding and viral
neutralization that was abrogated after pre-exposing virions to
proteases [14]. Subsequent experiments using a MAb, SAR1,
directed to 739ERDRD743 demonstrated that SAR1 effectively
neutralized HIV-1 by apparently post-attachment binding at lower
temperatures; negligible neutralization was observed when virus
and cells were pre-incubated at 37uC [16,17]. SAR1 was also
shown to effectively inhibit virus replication in HIV-1 infected cells
incubated in the presence of SAR1 antibody [16], likely through a
decrease in cell-cell spread mediated by SAR1 inhibition of HIV-1
gp41-induced cell-cell fusion [18]. On the basis of these antibody
accessibility studies, Dimmock and colleagues have proposed an
alternative model for the topology of the HIV-1 gp41 CTT that
predicts multiple MSDs and surface loops (Figure 1B) [14,15].
This multiple MSD topology model is compatible with various
studies that have identified intracellular partners proposed to
interact with CTT sequences [6,10,19,20,21], but is incompatible
with recent data indicating a requirement for both the Tyr-based
sorting signal 711GYSPL715 and the extreme C-terminal
dileucine sorting signal (boxed in red in Figure 1) in the CTT to
facilitate Env endocytosis from the cell surface [11]. [10,22].
Finally, more recent studies have examined the accessibility of
the lentivirus lytic peptide (LLP) regions of the CTT (c.f. Figure 1)
to antibody on Env-expressing cells [23]. Under native conditions,
cell surface Env was not reactive with LLP1 and LLP2-specific
antibodies, consistent with a sequestered localization of the LLP1
and LLP2 sequences [24]. Interestingly, however, when Env-
expressing cells were incubated with CD4- and CCR5-expressing
target cells at 31.5uC, binding of LLP2-specific antibodies was
observed [23]. LLP2-specific MAbs did not bind when effector
and target cells were incubated at 37uC, indicating a highly
transient exposure of the LLP2 sequence [23], consistent with
prior reports of LLP2 membrane association post-fusion [24].
These results indicate the need to reconsider the current static
model of CTT topology and suggest that the CTT may be a more
dynamic structure than previously thought.
In the current study, we sought to test the proposed topology
models by experimentally determining the surface exposure of the
KE sequences of gp41 for comparison to the external and internal
locations predicted by the respective CTT models. Towards this
goal, we have examined the accessibility of the KE to antibody
binding on the surface of Env-expressing cells and on the surface
of intact mature virions using a combination of flow cytometry,
immunoprecipitation, and surface plasmon resonance (SPR)
spectroscopy techniques that minimize the potential for disruption
of the lipid membrane, the integrity of which is crucial to topology
mapping studies (see Figure 2 for CTT sequences used). Our
results indicate that the KE is topologically distinct on the cell
surface as compared to the virion and that the topology of the
CTT may be more complex and dynamic than indicated by
current Env structural models.
Results
Exposure of CTT sequences on the surface of Env-
transfected cells
To experimentally determine the exposure of the KE on the
surface of Env-expressing cells, the antibody reactivity of
transfected cells expressing HIV-1 89.6 Env with the VSV-G tag
Figure 1. Schematic models of the HIV-1 CTT. A.) Traditional CTT model with one membrane-spanning a-helix and a completely
intracytoplasmic localization of the remaining CTT sequence. LLP domains have been placed at their presumed membrane-localized position. B.)
Alternative CTT model with multiple MSD segments as proposed by Hollier and Dimmock [15]. This model proposes three membrane-spanning b-
sheets and an extracellular localization of the KE.
doi:10.1371/journal.pone.0015261.g001
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substituted in the KE (VSV-G-KE) or LLP2 (VSV-G-LLP2)
segments was analyzed. The selected epitope allowed the use of a
high affinity commercial anti-VSV-G MAb to compare the
accessibility of a common epitope in the context of the KE
segment and in a putative internal LLP2 segment of the CTT
[23,24]. Cells transfected with VSV-G-KE or VSV-G-LLP2 were
compared to cells transfected with 89.6 WT following staining
with anti-VSV-G and anti-actin antibodies. Anti-actin was used as
a control for cellular membrane integrity, providing the ability to
distinguish VSV-G positive intact cells from cells with compro-
mised membranes.
As shown in Figure 3A, VSV-G-KE-expressing cells (middle)
exhibit increased VSV-G-specific staining with no increase in actin
staining compared to 89.6 WT (left) transfected cells, while VSV-
G-LLP2-expressing cells (right) stain for neither VSV-G nor actin,
similar to the control cells. Since the insertion of the VSV-G tag
into the KE strategically conserved a key epitope for an existing
KE-specific MAb (SAR1), cells expressing the various Env
constructs were also tested for reactivity with this native
sequence-specific MAb. All cells expressing Env show similarly
increased SAR1 reactivity compared to mock-transfected cells
without an increase in actin staining (Figure 3B). In addition to
confirming the KE antibody accessibility results obtained with
VSV-G-KE, this result also suggests that the observed lack of
staining of 89.6 WT and VSV-G-LLP2 in Figure 3A is not due to
decreased cell surface gp160 expression, as SAR1 reacted similarly
with all Envs. Finally, to demonstrate the sensitivity of the actin
stain to detect permeable membranes, SAR1 staining was repeated
on permeabilized cells (Figure 3C). When the cell membrane
integrity was compromised, anti-actin fluorescence intensity
increased at least 10-fold, and 75–85% of permeabilized cells
stained positive for actin. This result indicates that the lack of actin
staining observed in Figure 3A and 3B reflects intact cell
membranes and not poor actin reactivity.
Finally, as the CTT has been shown to contain signals
important for association with detergent-resistant membranes
(DRMs) [25], association of the Env constructs with detergent-
resistant membranes (DRMs) was determined. Cells expressing
89.6 WT, VSV-G-KE, and VSV-G-LLP2 were subjected to
membrane sucrose floatation gradients. As seen in Figure 4, all
three Env constructs exhibited similar association with DRMs,
suggesting that the VSV-G tag replacement strategy did not result
in disruption of cell surface Env distribution. Taken together, these
results indicate that the KE can be exposed on the surface of the
plasma membrane, as the KE sequence is accessible to antibody
binding in intact cells expressing Env, both in the context of the
VSV-G epitope tag substitution and the native sequence.
KE-specific antibodies do not bind to intact viral particles
Next, immunoprecipitation studies were performed to assess the
ability of MAbs directed at the KE to pull down intact viral
particles using protein G-coated paramagnetic beads. Both a
gp120-specific antibody (termed C11) and a gp41 ectodomain
specific antibody (7B2) were used to provide positive controls for
Env binding and virion pull down. A p24-specific MAb (183-H12-
5C) was used to detect disrupted virions in the pull down assays as
a control for virion integrity. Of particular importance, several
reference MAbs (2F5, 4E10, Z13e1) directed to the membrane
proximal external region (MPER) of gp41 were used as controls, as
this epitope is known to be closely associated with the membrane
surface [26,27,28,29]. Together these MAbs provided highly
specific controls for antibody accessibility to viral membrane-
Figure 2. Sequence alignment of variant Env CTT. Sequence alignment of the membrane-spanning domain (MSD) and CTT of the Env proteins
used in this study. All Env proteins were full-length gp160, however, only the sequences from K665 to the C-terminus are shown for simplicity.
Structural and sequence domains are indicated in boxes above the corresponding sequence. VSV-G epitope tag indicated in bold; SAR1 and 1577
epitope indicated in gray box. KE – Kennedy epitope; LLP – lentivirus lytic peptide, MSD – membrane spanning domain.
doi:10.1371/journal.pone.0015261.g002
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associated epitopes, as predicted for the KE sequences in the
Dimmock topology model (see Figure 1B). For intact virus
immune precipitations, the level of antibody reactivity to its target
antigen was measured by the relative level of viral p24 precipitated
by the anti-Env MAbs (without lytic agents) compared to the
amount of p24 (virus) input into the reaction.
To ensure that all the reference MAbs were able to bind their
target protein, immunoprecipitations were initially performed with
MAbs incubated with purified virions solubilized with Triton X-
100. The product immunoprecipitates were then characterized by
SDS-PAGE and western blot for the respective target protein (e.g.
C11 immunoblotted for gp120, 7B2 immunoblotted for gp41,
etc.). The open bars in Figure 5 summarize the average results
obtained for each MAb from three independent reactions with
detergent-solubilized viral preparations. These data demonstrate
that all of the reference MAbs effectively pulled down $50% of
the total amount of target protein from solubilized virions; in
contrast, the nonspecific IgG control precipitated less than 3% of
the virion p24 indicating minimal nonspecific precipitation under
these experimental conditions.
Having established that the MAbs were able to bind their target
antigen in this assay format, we next tested the ability of the
reference MAbs to precipitate intact virions under conditions
similar to those used above without detergent solubilization.
Results presented in Figure 5 (solid bars) demonstrate that only
MAbs specific for gp120 (C11) or the known gp41 ectodomain
epitopes (7B2, 2F5, 4E10, and z13e1) effectively pulled down the
intact virus particles, as measured by p24 levels in the
Figure 3. FACS analysis of intact Env-expressing cells demonstrates extracellular exposure of the KE sequence. Cells transfected with
HIV-1 89.6 WT, VSV-G-KE, or VSV-G-LLP2 were analyzed by FACS to determine VSV-G epitope accessibility to anti-VSV-G MAb. A.) Intact, non-
permeabilized Env-expressing cells were stained with a-VSV-G (AlexaFluor (AF) 700) and a-actin (AF 488). B.) Intact cells expressing Env were stained
for surface exposure of the KE using a native KE antibody, SAR1. C.) Same as (B) except cells were permeabilized prior to staining.
doi:10.1371/journal.pone.0015261.g003
Figure 4. VSV-G epitope insertions do not disrupt Env
association with detergent-resistant membranes. Env association
with detergent resistant membranes was determined by sucrose
gradient floatation followed by western blot analysis. Lane 1 represents
the top of the gradient and lane 12 the bottom of the gradient. Blots
were stained with anti-gp41 MAb Chessie 8 to determine the
localization of gp41 in the bands shown.
doi:10.1371/journal.pone.0015261.g004
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immunoprecipitate. In marked contrast, both KE-specific MAbs
(1577 and SAR1) failed to immunoprecipitate virus (p24) to
significant levels above the IgG control, indicating a lack of
reactivity of these reference MAbs with the KE in the context of
intact virions. Additionally, the p24-specific MAb (183-H12-5C)
also failed to pull down p24 in intact virions, confirming the
integrity of the virion preparation. Taken together, the results
from these immunoprecipitation experiments indicate that the KE
is not accessible to antibody binding in the context of intact viral
particles.
To complement these immunoprecipitation studies, binding
analyses of gp41-specific MAbs to purified virions in solution were
performed using SPR spectroscopy. This technique allowed the
assessment of qualitative differences in relative antibody affinity in
real time during the course of the interaction. Specifically, SPR
assays were used to address the possibility that both KE and
MPER-specific MAbs bound viral particles equally well, but that
KE MAb binding to virions was unstable during the washing
procedures used in the immunoprecipitation assay.
As shown in Figure 6, the SPR results demonstrate stable
binding of MAb 2F5 to the MPER of intact HIV-1 virions, but no
detectable binding of SAR1 to the KE of gp41 in intact virions,
despite the highly sensitive nature of this assay. These results are
consistent with our viral immunoprecipitation observations and
confirm that the KE is apparently inaccessible to antibody binding
on the surface of viral particles and that the observed difference in
KE accessibility in cells and viruses cannot be attributed to
differences in the stability of antibody binding.
Discussion
The current studies were designed to distinguish between the
two distinct topological models currently proposed for HIV-1 gp41
by determining the accessibility of key CTT sequences in the
context of virions and Env-expressing cells to binding by reference
MAbs. The results of these studies for the first time reveal in
parallel assays a marked difference in the accessibility to antibody
Figure 5. Anti-KE MAbs do not bind to intact virions. The indicated proteins and viral particles were immunoprecipitated using reference
MAbs coupled to protein G-coated paramagnetic beads. (Top) Open bars represent % of target antigen precipitated when incubated with solubilized
virus, while closed bars represent the % of input p24 precipitated by the corresponding MAb under native (intact virus) conditions. # =p,0.05 for
MAbs compared to IgG control with solubilized virus; * = p,0.05 for MAbs with intact virus compared to IgG control. (Bottom) Representative p24
bands immunoprecipitated using the MAbs indicated in top panel with intact virus (Intact) or the bands of the target antigen from each MAb in
detergent-disrupted virus (Solublized).
doi:10.1371/journal.pone.0015261.g005
Figure 6. Comparison of MPER and KE MAb binding using SPR
spectroscopy. MAbs 2F5 (MPER) and SAR1 (KE) were compared for
relative binding rates and affinity using SPR spectroscopy to monitor
antibody binding to purified intact HIV-1 virions. RU – resonance units.
doi:10.1371/journal.pone.0015261.g006
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binding of the KE in a primary-isolate Env expressed on the
surface of cells compared to intact virions. Thus, these observa-
tions indicate that the CTT may exist in different topologies
depending on the membrane environment, suggesting that the
CTT may actually be dynamic in its association with different lipid
membranes or other cofactors.
While the goal of this study was to distinguish between the
alternative models of CTT topology, the current data is only
partially compatible with both models. In the case of virion-
associated Env, the lack of KE exposure to antibody binding is
consistent with the classical model of Env topology (Figure 1A) in
which the entire CTT sequence is sequestered within the lipid
bilayer. In the case of Env expressed on the surface of cells, the
accessibility of KE to antibody binding (and the inaccessibility of
the LLP2) is consistent with an alternative Env topology (Figure 1B)
in which parts of the CTT are exposed to the exterior of the lipid
bilayer. To reconcile these two different models, it seems necessary
to discard the static model of Env topology and to assume a new
perspective in which CTT association with membranes is
dynamic, perhaps controlled by interactions with other membrane
binding proteins or lipid composition.
A dynamic model for CTT topology is consistent with the
published studies by the Dimmock lab [16,17] indicating that the
KE is inaccessible to inactivation by SAR1 in free virions, but that
the KE becomes exposed to SAR1 inactivation only after virion
binding to target cells. The current data are also consistent with
initial studies by Kennedy et al [12,13] demonstrating that rabbit
antiserum prepared against a KE synthetic peptide could
inactivate HIV-1, as these early studies used an assay format in
which the serum antibody was incubated with the virus and the
target cells. Further supporting the concept of a dynamic CTT
topology is the recent report indicating that the LLP2 domain of
the CTT is only accessible to antibody during cell-cell membrane
fusion, suggesting major changes in virion Env topology post
receptor binding [23]. Interestingly, this would not be the first case
of a viral envelope protein exhibiting a dynamic topology. The
large envelope glycoprotein of hepatitis B virus is initially inserted
into the endoplasmic reticulum membrane with its N-terminus
located in the cytoplasm[30]. After a post-translational maturation
process, the N-terminus is translocated across the membrane by
insertion of another transmembrane helix in about 50% of the
molecules [31]. It will be interesting and important to determine
the extent and precise localization of KE-exposed Env on the cell
surface.
Recent structural studies of diverse membrane proteins have
resulted in an increased appreciation of the complexity and
dynamics of membrane protein topology [30]. Earlier topology
models were based on the simple concept that membrane proteins
of the helix-bundle type were assembled from long hydrophobic
alpha helices that were oriented perpendicular to the membrane
plane [32]. However, based on high resolution structures of
membrane proteins obtained during the past decade, it is now
recognized that membrane helices can adopt a remarkable range
of orientations relative to a membrane lipid bilayer and that
membrane helices can dynamically reorient across the membrane
in response to changes in the environment [30]. Specifically, a
recent study has demonstrated that the six helix N-terminal
domain of LacY can undergo topological inversion due solely to
the introduction of phosphatidylethanolamine into the lipid
membrane, illustrating that environmental changes can cause
specific alterations in membrane protein topology [33]. Addition-
ally, recent advances in understanding the properties of the lipid
membrane have led to new insights into membrane protein-lipid
interactions [34,35]. In particular, hydrophobic matching of
protein transmembrane segment length to lipid domains of similar
thickness has been shown to affect membrane protein segregation,
structure, and function [35,36,37,38]. It is intriguing to consider,
in the context of data presented here, the possibility that the gp41
CTT may undergo a dynamic change in topology due to
alterations in the lipid environment. Alternatively, in order to
minimize hydrophobic mismatch, Env with the CTT in the
traditional topology could be selectively incorporated into the lipid
rafts that serve as the sites of virion assembly.
A second aspect of current membrane protein structure studies
that appears to be relevant to the case for a reconsideration of
HIV-1 CTT membrane topology is the unique role of arginine
(Arg) in membrane-associated proteins. While the early paradigm
predicted Arg residues to be excluded from hydrophobic
environments like a membrane lipid bilayer, more recent
structural data indicate unique biochemical properties of Arg that
produce unexpected functional properties for membrane proteins.
For example, Arg residues can be incorporated as critical
components of the membrane spanning domains of proteins, as
observed with highly conserved Arg residue in the MSD of HIV-1
(c.f. Figure 1). The ability of the positively charged Arg to be
located in a lipid environment is evidently due to the capacity of
the Arg guanidinium group to form an energetically favorable
cation-p bond with tryptophan, tyrosine, or phenylalanine residues
in a stacked helix [39,40]. Interestingly, a highly conserved Phe is
located three residues C-terminal to the Arg in the HIV-1 MSD
(Figure 2).
A second unique property of Arg is its ability in a repeat
sequence (or homopeptide) to mediate transport of proteins and
DNA or RNA across intact biological membranes, in contrast to
homopeptides of other charged amino acids such as lysine (Lys)
and histidine (His) that fail to efficiently cross lipid bilayers [41].
Thus membrane protein segments rich in Arg residues have a
propensity to cross biological membranes under certain environ-
mental conditions, offering the potential for a dynamic membrane
topology. For example, the Arg-rich helical S4 segment of the
voltage-gated potassium channel KvAP is proposed to move across
the membrane as the channel opens and closes in response to
changes in the membrane electric field [42]. While this was
initially controversial due to the number of Arg residues (four) in
the S4 segment, more recent studies have demonstrated that the
S4 segment can insert into the membrane of eukaryotic cells as a
transmembrane helix in spite of the four Arg residues [43]. These
findings, when viewed in light of observations by Lu et al [23]
demonstrating transient LLP2 exposure on Env-expressing cells
undergoing fusion, may provide an explanation for the predom-
inance of Arg residues in the HIV gp41 CTT relative to other
cationic residues
A unique characteristic of the gp41 CTT of HIV-1 is that it
contains two cationic amphipathic helical segments (LLP1 and
LLP2) that are rich in Arg. In addition, the CTT contains a
number of other highly conserved Arg residues. We and others
have previously shown that synthetic LLP1 and LLP2 peptides
assume a random coil conformation in aqueous environments, but
rapidly convert to a helical conformation in a hydrophobic or
membrane mimetic environment [44,45,46]. In addition, we have
shown that synthetic LLP1 and LLP2 peptides are able to readily
traverse biological membranes of intact mammalian cells. These
observations are consistent with the concept of the Arg-rich CTT
being intimately associated with the membrane lipids and being
able to cross the lipid bilayer of an intact viral or cell membrane.
Finally, we and others have previously reported that modifica-
tions in CTT length or amino acid composition can have marked
affects on global Env structure and function, including virion
Cell vs. Virion HIV gp41 C-Terminal Tail Topology
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incorporation, fusogenicity, and antibody reactivity. For example,
we found that the mutation of two Arg residues to glutamate (Glu)
residues in LLP2 of an HIV-1 provirus substantially reduced Env
fusogenicity and altered the antibody reactivity and neutralization
sensitivity of epitopes located in both the gp120 protein and the
ectodomain of gp41 [47]. These observations have been
interpreted to indicate that changes in CTT result in allosteric
alterations in global Env conformation that are reflected in altered
functional properties, including reduced fusogenicity. It is
interesting to speculate that altering the Arg content may affect
the association of the LLP segments with the lipid bilayer and
perhaps the ability of the CTT to traverse the membrane during
the fusion process.
As often happens in HIV-1 research, our efforts to test two
relatively simple models for CTT topology have indicated the
need to consider more complicated and dynamic models of CTT
membrane topology. This is perhaps a timely pursuit in light of the
new paradigms of membrane structure and the importance of
understanding the mechanisms by which the CTT serves as a
determinant of HIV-1 Env structure and function on the surface of
virions and cells.
Materials and Methods
Cells and virus preparations
HEK293T cells (ATCC) were maintained in DMEM (Invitro-
gen) supplemented with 10% (v/v) FBS. Cells were used at passage
numbers less than 30. Gradient purified aldrithiol-2-inactivated
HIV-1 NL4-3 virus (generously provided by Dr. Jeff Lifson, SAIC
Frederick, Inc) used in this study has been described previously
[48] and recently used for cryoelectron microscopy studies of
virion-associated Env [49,50,51,52]. The SAR1 hybridoma was a
kind gift from Dr. Nigel Dimmock.
VSV-G epitope tag substitutions
As described for topology mapping of other membrane proteins
[53,54,55], we determined the antibody reactivity of selected Env
constructs containing selected VSV-G epitope substitutions in the
CTT. For these studies, the codon-optimized Env gene of HIV-1
(89.6) was cloned into a p2CI vector derived from PCR2.1 by
insertion of the CMV promoter and polyA signal sequence from
pcDNA3.1(hygro) (Invitrogen) and PCR-amplified IRES-Neomy-
cin resistant sequence from pFB-Neo-LacZ vector (Stratagene).
Overlapping PCR was used for the construction of the VSV-G
substitution mutants of gp160. The two hybrid primers were
constructed containing VSV-G tag sequences at the 59-ends and
HIV gp160 specific sequences at the 39-ends of both the primers
used for the substitutions. Final overlapping PCR products were
then subcloned into the HIV-1 gp160 expression vector using the
appropriate restriction enzymes and the Rapid DNA Ligation Kit
(Roche Applied Science). All mutants were verified by DNA
sequencing.
Cell culture and transfections
HEK293T cells were plated into six-well plates 24 hours prior
to transfection. 80% confluent cells were transfected with 2.5 mg of
the selected HIV-1 Env mutant DNA using LipofectamineTM
LTX reagent and PLUSTM reagent, as recommended by the
manufacturer (Invitrogen).
Cellular FACS analysis
Cells were harvested 24 hours post-transfection by treatment
with 2 mM EDTA. Cells were resuspended and washed twice with
FACS wash buffer (1X PBS with 5% FBS) at 4uC prior to
antibody staining. Reference MAbs to VSV-G (Roche Diagnos-
tics), gp41 (SAR1), and actin (Sigma-Aldrich) were labeled
immediately prior to staining using Zenon labeling kits (Invitrogen)
following manufacturer’s instructions. 106 cells were dual-stained
by incubating with 5 mg fluorophore-labeled antibody (VSV-G or
gp41) and 7.5 mg fluorophore-labeled actin antibody for 30
minutes on ice. Following staining, cells were washed thrice with
FACS wash buffer at 4uC. Washed cells were resuspended and
stained with 7-amino-actinomycin D (7-AAD). Cells were not fixed
prior to analysis. Fluorescently-labeled cells were analyzed on a
FACSAria (BD Biosciences). Live, intact cells (7-AAD negative)
were selected for scatter characteristics, including selection of
single-cell populations by doublet-discrimination analysis. PMT
settings were adjusted on identically-stained mock transfected cells
prior to analysis of Env-transfected cells. Data was collected for
56104 7-AAD negative cells and analyzed for reactivity with
fluorescently-labeled VSV-G or gp41 and actin antibodies.
Isolation of detergent resistant membranes
HEK293T cells were transfected with 89.6 WT, VSV-G-KE, or
VSV-G-LLP2 plasmids. 48 hours post-transfection, cells were
subjected to sucrose gradient floatation as previously described
[56]. Briefly, cells were collected and washed in ice-cold 1X
phosphate buffered saline (PBS). Washed cells were extracted on
ice for 30 minutes with 0.5 ml ice-cold 1% Triton X-100 in NTE
buffer (25 mM Tris-HCl; 0.15 M NaCL; 5 mM EDTA; pH 7.5)
with phenylmethylsulfonyl fluoride and complete protease inhib-
itor (Roche). Cell lysates were centrifuged at 8,0006g for 10
minutes at 4uC. Clarified extracts were mixed with an equal
volume of 85% sucrose in NTE and loaded into a prechilled
centrifuge tube. Extracts were overlaid with 6 ml 30% sucrose in
NTE, followed by 5 ml 5% sucrose in NTE. Tubes were
centrifuged at 100,0006g for 18 hours at 4uC. The gradients
were fractionated from the top manually by pipetting into ,1 ml
fractions. Aliquots of the samples were precipitated with
trichloroacetic acid, resuspended in SDS-PAGE running buffer,
and subjected to SDS-PAGE followed by western blot with anti-
gp41 MAb Chessie 8. Blots were developed with PicoWest
substrate (Pierce) and visualized on X-ray film.
Viral immunoprecipitation and western blotting
Protein G Dynabeads (Invitrogen) were prepared according to
the manufacturer’s directions. Briefly, anti-Env or anti-Gag
antibodies (4 mg) were incubated with 20 ml protein G Dynabeads
in 35 ml citrate-phosphate buffer, pH 5.0, with gentle shaking for
45 minutes at room temperature. Isotype-matched IgG controls
were used for each species (murine, human, etc.) from which a
MAb was derived. Beads were washed thrice with 0.5 ml citrate-
phosphate buffer followed by resuspension in either 26 ml PBS (for
intact virus) or 26 ul PBS with 1% Triton X-100 (for lysed virus)
and 4 ml NL4-3 virus (equivalent to 1.1 mg p24). Virus-bead
suspensions were incubated at 4uC for one hour with gentle
shaking and subsequently washed thrice with 1X PBS. Following
the final wash, beads were resuspended in NuPAGE SDS-PAGE
buffer, heated at 70uC for 10 minutes, and the supernatant loaded
onto 4–12% Bis-Tris NuPAGE gels. Gels were electrophoresed
followed by transfer to polyvinylidene fluoride (PVDF) membranes
using the Invitrogen iBlot system. Blots were blocked for one hour
in 5% blotto (1X PBS with 5% dry milk). After blocking, blots
were cut to allow separate staining of gp120 (.60 kDa), gp41 (30–
60 kDa), and p24 (,30 kDa). gp120 was stained with rabbit anti-
gp120 (Advanced Biotechnologies, Inc.), gp41 stained with Chessie
8, and p24 stained with Ag3.0 for 1.5 hours at room temperature.
Blots were washed thrice with 1X PBS and 0.025% Tween 20
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(PBS-T), followed by incubation with appropriate secondary
antibody (anti-rabbit IgG or anti-mouse IgG conjugated to
horseradish peroxidase) for one hour at room temperature. Blots
were washed thrice in PBS-T with the gp120 blot receiving an
additional wash in 1X PBS with 0.1% Triton X-100. Finally, blots
were incubated with PicoWest substrate (Pierce) for one minute
and reassembled for visualization on X-ray film.
Western blot quantitation
Antibody IPs were quantified by densitometry analysis. For each
IP, three independent X-ray exposures were scanned and analyzed
using ImageJ (NIH). For intact virus, p24 bands, and for solublized
virus bands from each MAb’s target antigen, were selected for
each protein, and the integrated area under the densitometry
curve was compared to that of the viral input band to yield percent
of the input protein in the immunoprecipitate. Percent inputs for
each protein for each of the three exposures were averaged to yield
the overall percent input immunoprecipitated per experiment.
This was repeated for three independent experiments, and the
results were averaged to yield the final percent input immuno-
precipitated per antibody. One-way ANOVA analysis was
performed in Prism 5.0b with the Dunnett Multiple Comparison
test and IgG as the control column. The P value of the test was
,0.0001. Individual P values for antibodies compared to the IgG
control are indicated in each data set.
SPR spectroscopy analysis of antibody-virus interactions
Antibody-virus interactions were analyzed using SPR spectros-
copy using a Biacore 3000 instrument. Protein A was immobilized
on CM5 sensor chips as described [57,58]. For analysis of the
binding interaction, MAbs were captured on the protein A surface
to ,1500 RU with a protein A-only surface serving as a reference
surface to account for virus-protein A non-specific interactions.
Virus (2.5 mg/ml total protein; 172 mg/ml p24) diluted in 10 mM
sodium phosphate buffer, pH 7.2 was injected over parallel
reference and MAb-captured flowcells at 10 ml/min for 2 minutes.
A buffer-only injection served to account for MAb dissociation
from the protein A surface and was subtracted from each MAb
binding experiment. Thus, presented sensorgrams are double
referenced [59].
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